Innovating Works
LIPOBITS: Liposome based Biomimetic Treatment for auto immune diabetes T1D AHEAD THERAPEUTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Autoimmune diseases (AD) affect 5-10% of the global population and require chronic palliative treatments, resulting in lower quality of life...
2018-11-23 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.